论文部分内容阅读
柳胺苄心定(Labetalol,AH_(5158))是1978年世界卫生组织高血压专家座谈会上推荐的另一个治疗高血压的新药。化学结构式如下:动物实验和临床研究,一致地证明,本药是一种兼有阻断肾上腺素能α和β受体的新型
Labetalol (AH 5158) is another new antihypertensive drug recommended at the 1978 WHO Hypertension Symposium. The chemical structure is as follows: animal experiments and clinical studies have consistently demonstrated that the drug is a new block of both adrenergic alpha and beta receptors